IKT vs AMGN: Which Stock is Better?
Side-by-side comparison of Inhibikase Therapeutics Inc and Amgen Inc in 2026
IKT
Inhibikase Therapeutics Inc
$1.76
AMGN
Amgen Inc
$345.84
Key Metrics Comparison
| Metric | IKT | AMGN | Winner |
|---|---|---|---|
| Market Cap | $225.78M | $189.19B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | -1.0% | 0.1% | AMGN |
| Gross Margin | -3062780800.0% | 70.8% | AMGN |
Analyze IKT
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IKT or AMGN a better investment?
Comparing IKT and AMGN: Inhibikase Therapeutics Inc has a market cap of $225.78M while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IKT and AMGN?
IKT (Inhibikase Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IKT or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IKT or AMGN?
AMGN has higher revenue growth at 0.1% vs -1.0% for IKT.
Which company is more profitable: IKT or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -3062780800.0% for IKT.
Which is the larger company: IKT or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $225.78M for IKT.
Should I buy IKT or AMGN in 2026?
Both IKT and AMGN have investment merit. IKT trades at $1.76 while AMGN trades at $345.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IKT and AMGN stock?
Key differences: Market Cap ($225.78M vs $189.19B), P/E Ratio (N/A vs 24.7x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (-3062780800.0% vs 70.8%).